SphingoTec

Sphingotec email format

Verified email-pattern data for Sphingotec is currently limited. You can still use the company insights and contact sections below.
SphingoTec GmbH develops innovative biomarkers for diagnosis, prediction and monitoring of acute medical conditions, such as acute heart failure, acute kidney injury and circulatory shock, in order to support patient management and provide guidance for treatment strategies. Furthermore, sphingotec develops biomarkers for the prediction of health risks, such as obesity, cardiovascular diseases and breast cancer, in order to support prevention strategies. SphingoTec GmbH was established in 2002 by Dr. Andreas Bergmann was one of the founders of B.R.A.H.M.S. AG. As former Chief Research Officer, he was responsible for the development of the “gold standard” sepsis biomarker Procalcitonin (B.R.A.H.M.S. PCT™).

Company Details

Employees
20
Founded
-
Address
Neuendorfstraße, 15a,germany
Phone
+49 33 02/2 05 65-0
Email
in****@****otec.de
Industry
Biotechnology Research
HQ
Hennigsdorf, Brandenburg
Looking for a particular SphingoTec employee's phone or email?

Sphingotec Questions

Explore related pages

Related company profiles:

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant